Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions.
Excellent balance sheet and good value.
Share Price & News
How has Getinge's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: GETI B's share price has been volatile over the past 3 months.
7 Day Return
SE Medical Equipment
1 Year Return
SE Medical Equipment
Return vs Industry: GETI B exceeded the Swedish Medical Equipment industry which returned 5.7% over the past year.
Return vs Market: GETI B exceeded the Swedish Market which returned -10.3% over the past year.
Price Volatility Vs. Market
How volatile is Getinge's share price compared to the market and industry in the last 5 years?
Simply Wall St News
6 days ago | Simply Wall StAre Getinge's (STO:GETI B) Statutory Earnings A Good Guide To Its Underlying Profitability?
2 weeks ago | Simply Wall StGetinge AB (STO:GETI B) Delivered A Weaker ROE Than Its Industry
1 month ago | Simply Wall StCan You Imagine How Getinge's (STO:GETI B) Shareholders Feel About The 55% Share Price Increase?
Is Getinge undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: GETI B (SEK196.55) is trading below our estimate of fair value (SEK284.4)
Significantly Below Fair Value: GETI B is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: GETI B is good value based on its PE Ratio (43.8x) compared to the Medical Equipment industry average (47.4x).
PE vs Market: GETI B is poor value based on its PE Ratio (43.8x) compared to the Swedish market (14.1x).
Price to Earnings Growth Ratio
PEG Ratio: GETI B is poor value based on its PEG Ratio (2.6x)
Price to Book Ratio
PB vs Industry: GETI B is good value based on its PB Ratio (2.6x) compared to the SE Medical Equipment industry average (3.6x).
How is Getinge forecast to perform in the next 1 to 3 years based on estimates from 10 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: GETI B's forecast earnings growth (16.9% per year) is above the savings rate (-0.4%).
Earnings vs Market: GETI B's earnings (16.9% per year) are forecast to grow faster than the Swedish market (7.8% per year).
High Growth Earnings: GETI B's earnings are forecast to grow, but not significantly.
Revenue vs Market: GETI B's revenue (4% per year) is forecast to grow slower than the Swedish market (4.1% per year).
High Growth Revenue: GETI B's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: GETI B's Return on Equity is forecast to be low in 3 years time (9.8%).
How has Getinge performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: GETI B has high quality earnings.
Growing Profit Margin: GETI B became profitable in the past.
Past Earnings Growth Analysis
Earnings Trend: GETI B's earnings have declined by -34.8% per year over the past 5 years.
Accelerating Growth: GETI B has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.
Earnings vs Industry: GETI B has become profitable in the last year, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.6%).
Return on Equity
High ROE: GETI B's Return on Equity (6%) is considered low.
How is Getinge's financial position?
Financial Position Analysis
Short Term Liabilities: GETI B's short term assets (SEK14.5B) exceed its short term liabilities (SEK9.9B).
Long Term Liabilities: GETI B's short term assets (SEK14.5B) exceed its long term liabilities (SEK13.9B).
Debt to Equity History and Analysis
Debt Level: GETI B's debt to equity ratio (43.4%) is considered high.
Reducing Debt: GETI B's debt to equity ratio has reduced from 111% to 43.4% over the past 5 years.
Debt Coverage: GETI B's debt is well covered by operating cash flow (42.1%).
Interest Coverage: GETI B's interest payments on its debt are well covered by EBIT (6.6x coverage).
Inventory Level: GETI B has a low level of unsold assets or inventory.
Debt Coverage by Assets: GETI B's debt is covered by short term assets (assets are 1.6x debt).
What is Getinge's current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: GETI B's dividend (0.76%) isn’t notable compared to the bottom 25% of dividend payers in the Swedish market (2.14%).
High Dividend: GETI B's dividend (0.76%) is low compared to the top 25% of dividend payers in the Swedish market (6.55%).
Stability and Growth of Payments
Stable Dividend: GETI B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are stable.
Growing Dividend: GETI B is not paying a notable dividend for the Swedish market, therefore no need to check if payments are increasing.
Current Payout to Shareholders
Dividend Coverage: GETI B is not paying a notable dividend for the Swedish market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of GETI B's dividend in 3 years as they are not forecast to pay a notable one for the Swedish market.
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mattias Perjos (47yo)
Mr. Mattias Perjos has been the Chief Executive Officer and President at Getinge AB since March 27, 2017. Mr. Perjos serves as Chief Executive Officer at FlexLink Systems, Inc. Mr. Perjos has been the Dire ...
CEO Compensation Analysis
Compensation vs Market: Mattias's total compensation ($USD4.59M) is above average for companies of similar size in the Swedish market ($USD1.35M).
Compensation vs Earnings: Mattias's compensation has been consistent with company performance over the past year.
|CEO, President & Director||3yrs||kr46.04m||0.013% SEK6.8m|
|Chief Financial Officer||2.25yrs||no data||0.0048% SEK2.6m|
|Head of Investor Relations||no data||no data||no data|
|Executive Vice President of Quality & Regulatory Compliance||4.17yrs||no data||0.0013% SEK717.4k|
|General Counsel||no data||no data||no data|
|Executive Vice President of Communications & Brand Management||2.75yrs||no data||no data|
|Executive Vice President of Human Resources & Sustainability||3.17yrs||no data||0.00037% SEK198.1k|
|Chief Technology Officer of Surgical Workflows||4.17yrs||no data||no data|
|Chief Commercial Officer||2.25yrs||no data||0.00037% SEK198.1k|
|President of Acute Care Therapies||no data||no data||0.00040% SEK214.1k|
Experienced Management: GETI B's management team is considered experienced (3 years average tenure).
|CEO, President & Director||3yrs||kr46.04m||0.013% SEK6.8m|
|Independent Director||12.92yrs||kr852.00k||0.054% SEK28.9m|
|Vice Chairman of Board||0.17yr||kr684.00k||20.03% SEK10.7b|
|Independent Director||6.17yrs||kr684.00k||0.0019% SEK1.0m|
|Independent Director||9.92yrs||kr722.00k||0.0016% SEK883.3k|
|Independent Director||3yrs||kr684.00k||0.00011% SEK58.9k|
|Employee Representative Director||2.17yrs||no data||no data|
|Employee Representative Director||7.17yrs||no data||no data|
Experienced Board: GETI B's board of directors are considered experienced (4.6 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: GETI B insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Getinge AB's company bio, employee growth, exchange listings and data sources
- Name: Getinge AB
- Ticker: GETI B
- Exchange: OM
- Founded: 1904
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: kr53.534b
- Shares outstanding: 272.37m
- Website: https://www.getinge.com
Number of Employees
- Getinge AB
- Lindholmspiren 7
- Västra Götaland County
- 417 56
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|GNGB.F||OTCPK (Pink Sheets LLC)||Yes||Class B Shares||US||USD||May 1993|
|GETI B||OM (OMX Nordic Exchange Stockholm)||Yes||Class B Shares||SE||SEK||May 1993|
|GTN||DB (Deutsche Boerse AG)||Yes||Class B Shares||DE||EUR||May 1993|
|0GZV||LSE (London Stock Exchange)||Yes||Class B Shares||GB||SEK||May 1993|
|GETIBS||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Class B Shares||GB||SEK||May 1993|
|GNGB.Y||OTCPK (Pink Sheets LLC)||UNSPONSORD ADR||US||USD||Oct 2008|
Getinge AB provides products and solutions for operating rooms, intensive-care units, sterilization departments, and life science companies and institutions. The company operates through Acute Care Therapies, Surgical Workflows, and Life Science segments. It offers practice-oriented monitoring systems and disposables; anesthesia, beating heart surgery, and ceiling devices; washer-disinfectors, consumables, and IT-solutions; connected solutions; consumables products; drain products; endoscope reprocessing; endoscopic vessel harvesting systems; extracorporeal life support or extracorporeal membrane oxygenation products; inspection and packaging services; intra-aortic balloon counter pulsation therapies; critical care ventilators; modular room systems; operating lights; operating tables and accessories; operating room (OR) furniture; OR integration systems; patient flow management solutions; patient transport solutions; sealing equipment; sterile supply management and traceability solutions; sterilizers; surgical assist systems; surgical perfusion components; loading and distribution trolleys; trays and baskets; and after sales consulting services. The company also provides automated bedding handling equipment, closure processing systems, washers, and isolation and sterile transfer products; professional financial advisory services to hospitals and medical facilities; and education and training services. It offers its products through a network of proprietary sales companies, as well as through agents and distributors in Europe, the Middle East, Africa, the Americas, Asia, and Pacific. The company has a strategic partnership with Verb Surgical Inc. to develop digital surgery solutions. Getinge AB was founded in 1904 and is headquartered in Gothenburg, Sweden.
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2020/03/30 20:59|
|End of Day Share Price||2020/03/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.